That's why I don't believe the gap will ever be filled unless complete failure raises its ugly head. Dilution might be once again indicted in the near future but (and its a big butt) the collaborations will overcome any setback in pps when validated.
IMO we will break through that $1.50 and rise to new higher lows this week
RE "The company plans to initiate an open-label multi-center, randomized Phase II trial"
So what? Do you have any idea how much time passes from "plans to initiate" to actual data in hand to PR? Do you have any idea how much DILUTION happens between those 2 points in time?
as time has proven over and over, that is NOT a recipe for a rising stock price.